1	Pyrrolidine	Pyrrolidine	_	_	_	_	_	_	_
2	dithiocarbamate	dithiocarbamate	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	potent	potent	_	_	_	_	_	_	_
6	inhibitor	inhibitor	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	nuclear	nuclear	_	_	_	_	_	_	_
9	factor	factor	_	_	_	_	_	_	_
10	kappa	kappa	_	_	_	_	_	_	_
11	B	B	_	_	_	_	_	_	_
12	(	(	_	_	_	_	_	_	_
13	NF-kappa	NF-kappa	_	_	_	_	_	_	_
14	B	B	_	_	_	_	_	_	_
15	)	)	_	_	_	_	_	_	_
16	activation	activation	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	prevents	prevent	_	_	_	_	_	_	_
19	apoptosis	apoptosis	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	human	human	_	_	_	_	_	_	_
22	promyelocytic	promyelocytic	_	_	_	_	_	_	_
23	leukemia	leukemia	_	_	_	_	_	_	_
24	HL-60	hl-60	_	_	_	_	_	_	_
25	cells	cell	_	_	_	_	_	_	_
26	and	and	_	_	_	_	_	_	_
27	thymocytes	thymocyte	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	examined	examine	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	effect	effect	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	pyrrolidine	pyrrolidine	_	_	_	_	_	_	_
7	dithiocarbamate	dithiocarbamate	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	PDTC	PDTC	_	_	_	_	_	_	_
10	)	)	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	which	which	_	_	_	_	_	_	_
13	potently	potently	_	_	_	_	_	_	_
14	blocks	block	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	activation	activation	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	nuclear	nuclear	_	_	_	_	_	_	_
19	factor	factor	_	_	_	_	_	_	_
20	kappa	kappa	_	_	_	_	_	_	_
21	B	B	_	_	_	_	_	_	_
22	(	(	_	_	_	_	_	_	_
23	NF-kappa	NF-kappa	_	_	_	_	_	_	_
24	B	B	_	_	_	_	_	_	_
25	)	)	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	on	on	_	_	_	_	_	_	_
28	the	the	_	_	_	_	_	_	_
29	induction	induction	_	_	_	_	_	_	_
30	of	of	_	_	_	_	_	_	_
31	apoptosis	apoptosis	_	_	_	_	_	_	_
32	by	by	_	_	_	_	_	_	_
33	a	a	_	_	_	_	_	_	_
34	variety	variety	_	_	_	_	_	_	_
35	of	of	_	_	_	_	_	_	_
36	agents	agent	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

1	Treatment	Treatment	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	human	human	_	_	_	_	_	_	_
5	promyelocytic	promyelocytic	_	_	_	_	_	_	_
6	leukemia	leukemia	_	_	_	_	_	_	_
7	cell	cell	_	_	_	_	_	_	_
8	line	line	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	HL-60	HL-60	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	with	with	_	_	_	_	_	_	_
13	10	10	_	_	_	_	_	_	_
14	micrograms/mL	micrograms/ml	_	_	_	_	_	_	_
15	etoposide	etoposide	_	_	_	_	_	_	_
16	or	or	_	_	_	_	_	_	_
17	2	2	_	_	_	_	_	_	_
18	microM	microm	_	_	_	_	_	_	_
19	1-beta-D-arabinofuranosylcytosine	1-beta-d-arabinofuranosylcytosine	_	_	_	_	_	_	_
20	induced	induce	_	_	_	_	_	_	_
21	NF-kappa	NF-kappa	_	_	_	_	_	_	_
22	B	B	_	_	_	_	_	_	_
23	activation	activation	_	_	_	_	_	_	_
24	within	within	_	_	_	_	_	_	_
25	1	1	_	_	_	_	_	_	_
26	hr	hr	_	_	_	_	_	_	_
27	and	and	_	_	_	_	_	_	_
28	subsequently	subsequently	_	_	_	_	_	_	_
29	caused	cause	_	_	_	_	_	_	_
30	apoptosis	apoptosis	_	_	_	_	_	_	_
31	within	within	_	_	_	_	_	_	_
32	3-4	3-4	_	_	_	_	_	_	_
33	hr	hr	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	simultaneous	simultaneous	_	_	_	_	_	_	_
3	addition	addition	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	50-500	50-500	_	_	_	_	_	_	_
6	microM	microM	_	_	_	_	_	_	_
7	PDTC	PDTC	_	_	_	_	_	_	_
8	with	with	_	_	_	_	_	_	_
9	these	these	_	_	_	_	_	_	_
10	agents	agent	_	_	_	_	_	_	_
11	blocked	block	_	_	_	_	_	_	_
12	NF-kappa	NF-kappa	_	_	_	_	_	_	_
13	B	B	_	_	_	_	_	_	_
14	activation	activation	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	completely	completely	_	_	_	_	_	_	_
17	abrogated	abrogate	_	_	_	_	_	_	_
18	both	both	_	_	_	_	_	_	_
19	morphologically	morphologically	_	_	_	_	_	_	_
20	apoptotic	apoptotic	_	_	_	_	_	_	_
21	changes	change	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	internucleosomal	internucleosomal	_	_	_	_	_	_	_
24	DNA	dna	_	_	_	_	_	_	_
25	fragmentation	fragmentation	_	_	_	_	_	_	_
26	for	for	_	_	_	_	_	_	_
27	up	up	_	_	_	_	_	_	_
28	to	to	_	_	_	_	_	_	_
29	6	6	_	_	_	_	_	_	_
30	hr	hr	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	PDTC	PDTC	_	_	_	_	_	_	_
4	failed	fail	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	inhibit	inhibit	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	endonuclease	endonuclease	_	_	_	_	_	_	_
9	activity	activity	_	_	_	_	_	_	_
10	contained	contain	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	whole	whole	_	_	_	_	_	_	_
14	cell	cell	_	_	_	_	_	_	_
15	lysates	lysate	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	inhibitory	inhibitory	_	_	_	_	_	_	_
3	effect	effect	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	PDTC	PDTC	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	also	also	_	_	_	_	_	_	_
8	observed	observe	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	etoposide-	etoposide-	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	dexamethasone-induced	dexamethasone-induced	_	_	_	_	_	_	_
13	apoptosis	apoptosis	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	human	human	_	_	_	_	_	_	_
16	thymocytes	thymocyte	_	_	_	_	_	_	_
17	at	at	_	_	_	_	_	_	_
18	a	a	_	_	_	_	_	_	_
19	concentration	concentration	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	1-10	1-10	_	_	_	_	_	_	_
22	microM	microm	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Since	since	_	_	_	_	_	_	_
2	PDTC	PDTC	_	_	_	_	_	_	_
3	has	have	_	_	_	_	_	_	_
4	both	both	_	_	_	_	_	_	_
5	antioxidant	antioxidant	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	metal-ion	metal-ion	_	_	_	_	_	_	_
8	chelating	chelate	_	_	_	_	_	_	_
9	activities	activity	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	we	we	_	_	_	_	_	_	_
12	tested	test	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	effects	effect	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	N-acetyl-L-cysteine	N-acetyl-L-cysteine	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	NAC	NAC	_	_	_	_	_	_	_
19	)	)	_	_	_	_	_	_	_
20	(	(	_	_	_	_	_	_	_
21	antioxidant	antioxidant	_	_	_	_	_	_	_
22	)	)	_	_	_	_	_	_	_
23	or	or	_	_	_	_	_	_	_
24	o-phenanthroline	o-phenanthroline	_	_	_	_	_	_	_
25	(	(	_	_	_	_	_	_	_
26	OP	OP	_	_	_	_	_	_	_
27	)	)	_	_	_	_	_	_	_
28	(	(	_	_	_	_	_	_	_
29	metal-ion	metal-ion	_	_	_	_	_	_	_
30	chelator	chelator	_	_	_	_	_	_	_
31	)	)	_	_	_	_	_	_	_
32	on	on	_	_	_	_	_	_	_
33	the	the	_	_	_	_	_	_	_
34	induction	induction	_	_	_	_	_	_	_
35	of	of	_	_	_	_	_	_	_
36	apoptosis	apoptosis	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

1	Pretreatment	Pretreatment	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	HL-60	HL-60	_	_	_	_	_	_	_
4	cells	cell	_	_	_	_	_	_	_
5	or	or	_	_	_	_	_	_	_
6	thymocytes	thymocyte	_	_	_	_	_	_	_
7	with	with	_	_	_	_	_	_	_
8	100-500	100-500	_	_	_	_	_	_	_
9	microM	microM	_	_	_	_	_	_	_
10	OP	OP	_	_	_	_	_	_	_
11	for	for	_	_	_	_	_	_	_
12	2	2	_	_	_	_	_	_	_
13	hr	hr	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	but	but	_	_	_	_	_	_	_
16	not	not	_	_	_	_	_	_	_
17	10-60	10-60	_	_	_	_	_	_	_
18	mM	mM	_	_	_	_	_	_	_
19	NAC	NAC	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	suppressed	suppress	_	_	_	_	_	_	_
22	subsequent	subsequent	_	_	_	_	_	_	_
23	occurrence	occurrence	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	apoptosis	apoptosis	_	_	_	_	_	_	_
26	induced	induce	_	_	_	_	_	_	_
27	by	by	_	_	_	_	_	_	_
28	etoposide	etoposide	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	suggest	suggest	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	activation	activation	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	NF-kappa	NF-kappa	_	_	_	_	_	_	_
9	B	B	_	_	_	_	_	_	_
10	plays	play	_	_	_	_	_	_	_
11	an	an	_	_	_	_	_	_	_
12	important	important	_	_	_	_	_	_	_
13	role	role	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	apoptotic	apoptotic	_	_	_	_	_	_	_
17	process	process	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	human	human	_	_	_	_	_	_	_
20	hematopoietic	hematopoietic	_	_	_	_	_	_	_
21	cells	cell	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

